Liquid Biopsy Market Future Scope in Early Cancer Detection and Monitoring 2031
The Liquid Biopsy Market is benefiting from the expansion of companion diagnostics and targeted therapies. Identification of molecular alterations can help guide therapeutic decisions when specific biomarkers are clinically relevant.
The Liquid Biopsy Market was estimated at US$ 4.57 billion in 2021 and is expected to reach US$ 12.69 million by 2031, registering an estimated CAGR of 11.2%...
0 Комментарии
0 Поделились